Service Quote Request
Please fill out the form below with your detailed inquiry.
-
PHONE: 1-866-918-6812
AAV6 vs. Ark313: Which Vector Is Better for T-Cell Gene Delivery?
Among the many AAV serotypes available for gene delivery, AAV6 has long been considered one of the leading vectors for T-cell engineering. More recently, Ark313—an engineered AAV6-derived capsid—has emerged as a highly specialized vector with dramatically improved performance in murine T cells.
What Is AAV6?
AAV6 is a naturally occurring adeno-associated virus serotype widely used for:
- Ex vivo T-cell engineering
- CAR-T and TCR-T development
- CRISPR-mediated knock-in workflows
- Delivery of HDR donor templates
AAV6 is especially effective in human primary T cells, making it a common choice for clinical and translational cell therapy applications.
What Is Ark313?
Ark313 is an engineered capsid derived from AAV6 through directed evolution and capsid optimization. It was specifically developed to overcome the relatively limited ability of native AAV6 to efficiently transduce murine T cells.
Compared with AAV6, Ark313 demonstrates:
- Dramatically enhanced mouse T-cell transduction
- Efficient in vivo targeting of murine T cells
- Improved CRISPR/HDR donor delivery
- Higher genome editing efficiency in mouse models
AAV6 vs. Ark313 Comparison
| Feature | AAV6 | Ark313 |
|---|---|---|
| Capsid Type | Natural serotype | Engineered AAV6-derived capsid |
| Primary Strength | Human T-cell transduction | Murine T-cell transduction |
| Human T-cell Efficiency | Excellent | Reduced |
| Mouse T-cell Efficiency | Moderate | Very high |
| In Vivo Mouse T-cell Targeting | Limited | Strong |
| CRISPR HDR Delivery in Mouse T Cells | Moderate | Highly efficient |
| Typical Applications | Human CAR-T engineering | Mouse immunology and gene editing |
| Species Preference | Human | Mouse |
Studies have reported that Ark313 can achieve up to ~30–46-fold higher murine T-cell transduction efficiency compared with conventional AAV6 under certain experimental conditions.
Why Does Ark313 Perform Better in Mouse T Cells?
The enhanced performance of Ark313 appears to result from engineered capsid modifications that improve interaction with murine T-cell surface receptors, including pathways associated with Qa-2–related uptake mechanisms.
As a result, Ark313 enables:
- Efficient genome editing in mouse T cells
- Reduced dependence on electroporation/nucleofection
- Improved in vivo delivery following systemic administration
- Enhanced HDR-mediated gene knock-in
Which Vector Should You Choose?
Choose AAV6 if your project involves:
- Human primary T cells
- Clinical or translational CAR-T workflows
- Human CRISPR editing applications
- Established ex vivo engineering protocols
Choose Ark313 if your project involves:
- Mouse T-cell engineering
- Murine immunology studies
- In vivo T-cell targeting in mice
- High-efficiency CRISPR knock-in in murine systems
Conclusion
While AAV6 remains the gold standard for many human T-cell engineering applications, Ark313 represents a major advancement for murine T-cell gene delivery. By specifically evolving the AAV6 capsid for mouse T-cell tropism, Ark313 achieves substantially improved transduction and genome editing efficiency in murine systems.
For researchers working in mouse immunology, CRISPR engineering, or in vivo T-cell targeting, Ark313 may provide a significant advantage over conventional AAV6.
Important updates waiting for you!
Enter your email address below and subscribe to our newsletter